comparison test-data/out1.tabular @ 0:28d72b995c6b draft default tip

planemo upload for repository https://github.com/galaxyproject/tools-devteam/tree/master/tools/dgidb_annotator commit 5a4e0ca9992af3a6e5ed2b533f04bb82ce761e0b
author devteam
date Mon, 09 Nov 2015 11:29:28 -0500
parents
children
comparison
equal deleted inserted replaced
-1:000000000000 0:28d72b995c6b
1 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a SUNITINIB TEND
2 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a IMATINIB TEND
3 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor MOTESANIB MyCancerGenome
4 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor VANDETANIB MyCancerGenome
5 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SORAFENIB MyCancerGenome
6 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor REGORAFENIB MyCancerGenome
7 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AMUVATINIB MyCancerGenome
8 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SUNITINIB MyCancerGenome
9 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor CABOZANTINIB MyCancerGenome
10 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor SUNITINIB TALC
11 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor VANDETANIB TALC
12 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor MOTESANIB TALC
13 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor CABOZANTINIB TALC
14 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor REGORAFENIB TALC
15 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor LENVATINIB TALC
16 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AMUVATINIB TALC
17 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE inhibitor AT9283 TALC
18 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a VANDETANIB ClearityFoundationClinicalTrial
19 RET gene1 RET ret proto-oncogene TYROSINE KINASE,DRUGGABLE GENOME,KINASE,CLINICALLY ACTIONABLE n/a DOVITINIB ClearityFoundationClinicalTrial
20 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist AEG40826 TALC
21 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist TL 32711 TALC
22 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist AT-406 TALC
23 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist GDC0917 TALC
24 BIRC3 gene2 BIRC3 baculoviral IAP repeat containing 3 antagonist LCL161 TALC
25 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a E7449 ClearityFoundationBiomarkers
26 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a NIRAPARIB ClearityFoundationBiomarkers
27 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a OLAPARIB ClearityFoundationBiomarkers
28 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a BMN673 ClearityFoundationBiomarkers
29 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a RUCAPARIB ClearityFoundationBiomarkers
30 ATM gene3 ATM ataxia telangiectasia mutated PHOSPHATIDYLINOSITOL 3 KINASE,DRUGGABLE GENOME,CLINICALLY ACTIONABLE,SERINE THREONINE KINASE,KINASE,TUMOR SUPPRESSOR,DNA REPAIR n/a VELIPARIB ClearityFoundationBiomarkers
31 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a VANDETANIB ClearityFoundationBiomarkers
32 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a EVEROLIMUS ClearityFoundationBiomarkers
33 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a TEMSIROLIMUS ClearityFoundationBiomarkers
34 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a GDC-0973 ClearityFoundationBiomarkers
35 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a MEK162 ClearityFoundationBiomarkers
36 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PD-325901 ClearityFoundationBiomarkers
37 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a RAFAMETINIB ClearityFoundationBiomarkers
38 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a SELUMETINIB ClearityFoundationBiomarkers
39 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a TRAMETINIB ClearityFoundationBiomarkers
40 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a CETUXIMAB ClearityFoundationBiomarkers
41 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a ERLOTINIB ClearityFoundationBiomarkers
42 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a GEFITINIB ClearityFoundationBiomarkers
43 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PANITUMUMAB ClearityFoundationBiomarkers
44 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE n/a PIMASERTIB ClearityFoundationBiomarkers
45 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE inhibitor REOLYSIN CancerCommons
46 KRAS gene4 KRAS v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog CLINICALLY ACTIONABLE vaccine RAS PEPTIDE CANCER VACCINE TALC